The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Ten-Year Outcome of Subthalamic Stimulation in Parkinson Disease: A Blinded Evaluation
Abstract
OBJECTIVE: To assess the 10-year motor outcome of deep brain stimulation of the subthalamic nucleus (STN-DBS) in patients with Parkinson disease (PD). DESIGN: Patients with PD with bilateral STN-DBS were assessed according to the Core Assessment Program for Surgical Interventional Therapies in Parkinson's Disease protocol and videotaped at baseline and 1, 5, and 10 years after surgery. An independent rater blinded to stimulation and medication condition scored the 10-year video assessments. SETTING: Movement Disorders Centre, Toronto Western Hospital, University Health Network, University of Toronto. PATIENTS: Eighteen patients with advanced PD and 10-year follow-up of STN-DBS. INTERVENTION: Bilateral STN-DBS surgery. MAIN OUTCOME MEASURES: The primary outcome was the change in blinded Unified Parkinson's Disease Rating Scale (UPDRS) motor scores/subscores between the no medication/stimulation condition vs the no medication/no stimulation condition at 10 years. Secondary outcomes were the changes in blinded UPDRS motor scores between the medication/no stimulation and medication/stimulation conditions, UPDRS II scores, UPDRS IV dyskinesia and motor fluctuations scores, and anti-PD medication dose (levodopa equivalent daily dose) at different points. RESULTS: In the 18 patients available for follow-up at 10 years, STN-DBS still significantly improved the UPDRS total motor score (P = .007) and resting and action tremor (P < .01 and P = .02, respectively) and bradykinesia (P = .01) subscores. The UPDRS II scores in the medication and no medication conditions, UPDRS IV dyskinesia and motor fluctuations scores, and the levodopa equivalent daily dose were also significantly reduced compared with baseline. Axial signs showed the most progressive decline in stimulation and levodopa response over the years. CONCLUSION: This class III study provides evidence that stimulation-induced motor improvement was sustained overall at 10 years, although part of the initial benefit wore off mainly because of progressive loss of benefit on axial signs over time.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.181 · Cited by 10,378
Unified Parkinson's Disease Rating Scale
(2012) · SpringerReference · doi:10.1007/springerreference_184495 · Cited by 3,066
A Randomized Trial of Deep-Brain Stimulation for Parkinson's Disease
Deuschl, G., Schade-Brittinger, C., Krack, P., Volkmann, J., Schäfer, H., Bötzel, K., Daniels, C., Deutschländer, A., Dillmann, U., Eisner, W., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060281 · Cited by 2,944
Krack, P., Batir, A., Van Blercom, N., Chabardes, S., Fraix, V., Ardouin, C., Koudsie, A., Limousin, P. D., Benazzouz, A., LeBas, J. F., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035275 · Cited by 2,249
The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
Hely, M. A., Reid, W. G. J., Adena, M. A., Halliday, G. M., & Morris, J. G. L. (2008) · Movement Disorders · doi:10.1002/mds.21956 · Cited by 2,246
Weaver, F. M. (2009) · JAMA · doi:10.1001/jama.2008.929 · Cited by 1,525
Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation
Limousin, P., Pollak, P., Benazzouz, A., Hoffmann, D., Le Bas, J.-F., Perret, J. E., Benabid, A.-L., & Broussolle, E. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90062-4 · Cited by 1,392
Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up
Rodriguez-Oroz, M. C., Obeso, J. A., Lang, A. E., Houeto, J.-L., Pollak, P., Rehncrona, S., Kulisevsky, J., Albanese, A., Volkmann, J., Hariz, M. I., et al. (2005) · Brain · doi:10.1093/brain/awh571 · Cited by 1,057
Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD)
Defer, G.-L., Widner, H., Mari�, R.-M., R�my, P., Levivier, M., & Conference Participants: Conference Participants: G. L. Defer, M. (. (1999) · Movement Disorders · doi:10.1002/1531-8257(199907)14:4<572::aid-mds1005>3.0.co;2-c · Cited by 865
Williams, A., Gill, S., Varma, T., Jenkinson, C., Quinn, N., Mitchell, R., Scott, R., Ives, N., Rick, C., Daniels, J., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70093-4 · Cited by 733
Kumar, R., Lozano, A. M., Kim, Y. J., Hutchison, W. D., Sime, E., Halket, E., & Lang, A. E. (1998) · Neurology · doi:10.1212/wnl.51.3.850 · Cited by 634
Moro, E., Lozano, A. M., Pollak, P., Agid, Y., Rehncrona, S., Volkmann, J., Kulisevsky, J., Obeso, J. A., Albanese, A., Hariz, M. I., et al. (2010) · Movement Disorders · doi:10.1002/mds.22735 · Cited by 468
Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants
Fasano, A., Romito, L. M., Daniele, A., Piano, C., Zinno, M., Bentivoglio, A. R., & Albanese, A. (2010) · Brain · doi:10.1093/brain/awq221 · Cited by 429
Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson’s disease
Moro, E., Scerrati, M., Romito, L. M. A., Roselli, R., Tonali, P., & Albanese, A. (1999) · Neurology · doi:10.1212/wnl.53.1.85 · Cited by 420
How do parkinsonian signs return after discontinuation of subthalamic DBS?
Temperli, P., Ghika, J., Villemure, J.-G., Burkhard, P. R., Bogousslavsky, J., & Vingerhoets, F. J. G. (2003) · Neurology · doi:10.1212/wnl.60.1.78 · Cited by 418
STN-DBS frequency effects on freezing of gait in advanced Parkinson disease
Moreau, C., Defebvre, L., Destée, A., Bleuse, S., Clement, F., Blatt, J. L., Krystkowiak, P., & Devos, D. (2008) · Neurology · doi:10.1212/01.wnl.0000303972.16279.46 · Cited by 385
Selegiline slows the progression of the symptoms of Parkinson disease
Pålhagen, S., Heinonen, E., Hägglund, J., Kaugesaar, T., Mäki-Ikola, O., Palm, R., & the Swedish Parkinson Study Group (2006) · Neurology · doi:10.1212/01.wnl.0000204007.46190.54 · Cited by 271
Levodopa response in long‐term bilateral subthalamic stimulation for Parkinson's disease
Piboolnurak, P., Lang, A. E., Lozano, A. M., Miyasaki, J., Saint-Cyr, J., Poon, Y., Hutchison, W., Dostrovsky, J., & Moro, E. (2007) · Movement Disorders · doi:10.1002/mds.21482 · Cited by 143
Subthalamic Nucleus Stimulation: Improvements in Outcome With Reprogramming
Moro, E., Poon, Y. W., Lozano, A. M., Saint‐Cyr, J. A., & Lang, A. E. (2006) · Archives of Neurology · doi:10.1001/archneur.63.9.1266 · Cited by 139
Differential progression of motor impairment in levodopa-treated Parkinson's disease
Goetz, C. G., Stebbins, G. T., & Blasucci, L. M. (2000) · Movement Disorders · Cited by 91
Response to levodopa in parkinsonian patients with bilateral subthalamic nucleus stimulation
Moro, E., Esselink, R. A. J., Benabid, A. L., & Pollak, P. (2002) · Brain · doi:10.1093/brain/awf249 · Cited by 86
Cited by
Adaptive deep brain stimulation in advanced Parkinson disease.
Little, S., Pogosyan, A., Neal, S., Zavala, B., Zrinzo, L., Hariz, M., Foltynie, T., Limousin, P., Ashkan, K., FitzGerald, J., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23951 · Cited by 1,374
Probing and regulating dysfunctional circuits using deep brain stimulation
Lozano, A. M., & Lipsman, N. (2013) · Neuron · doi:10.1016/j.neuron.2013.01.020 · Cited by 665
Self-citationDeep-Brain Stimulation for Parkinson's Disease
Okun, M. S. (2012) · New England Journal of Medicine · doi:10.1056/nejmct1208070 · Cited by 541
Long-term outcomes of deep brain stimulation in Parkinson disease
Limousin, P., & Foltynie, T. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0145-9 · Cited by 480
Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation
Fasano, A., Daniele, A., & Albanese, A. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70049-2 · Cited by 437
Metadata
- Authors
- Castrioto, A.
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2011-12-01
- Volume
- 68
- Issue
- 12
- Pages
- 1550
- ISSN
- 0003-9942 (ISSN-L)
- OpenAlex
- W2061935704
- Cited by
- 455
- References
- 21
- FWCI
- 21.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.